Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.

Journal of acquired immune deficiency syndromes (1999) - 1 Jan 2001

Lafeuillade A, Poggi C, Chadapaud S, Hittinger G, Chouraqui M, Pisapia M, Delbeke E

Abstract excerpt

A pilot study of a combination of highly active antiretroviral therapy (HAART) and cytokines in early HIV-1 infection has been undertaken to test the hypothesis that HIV-1 remission can be reached with this strategy by flushing latently infected viral reservoirs. Ten previously antiretroviral naive patients have received a combination of zidovudine, lamivudine, didanosine, saquinavir, and ritonavir for 72 weeks....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Annexin A5
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coculture Techniques

Share to Lymph Nodes

Share to Pilot Projects

Share to Proviruses

Share to T-Lymphocyte Subsets

Share to Viremia

Source

Identifiers

PMID: 11176268
DOI: 10.1097/00126334-200101010-00006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.PMID 11176268Read ↗

HIV/AIDS eradicationSemantic proximity Read ↗

Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).Semantic proximity Read ↗

The Current Status of Latency Reversing Agents for HIV-1 RemissionSemantic proximity Read ↗

Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial.Semantic proximity Read ↗

Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.Semantic proximity Read ↗

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.Semantic proximity Read ↗

Positive Effects of Combined Antiretroviral Therapy on CD4 <sup>+</sup> T Cell Homeostasis and Function in Advanced HIV DiseaseSemantic proximity Read ↗

Can immune system "small talk" be broadcast as anti-HIV therapy?Semantic proximity Read ↗

Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads.Semantic proximity Read ↗

Human immunodeficiency virus drug therapy and virus loadSemantic proximity Read ↗

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.Semantic proximity Read ↗

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.